COVID-19 vaccinations summary

Second Boosters Administered 1,036,127
Total Doses Administered 12,988,268
First Boosters Administered 2,774,026
Percentage of 12+ who have completed primary course 86.7%
Percentage of eligible 50+ who have received second booster 56.7%
Percentage of eligible 18+ who have received first booster 74.1%

 

Metrics on this page can use one of two views of the data - An operational view or a person view.

The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.

The person view includes all people that are currently alive and in the latest Health Service User (HSU) population. The current HSU in use is the financial year 2022/23 HSU (FY2022/23 HSU). The HSU is an estimate of the population using the health system in New Zealand. A person is included in the HSU if they use health services (including births and deaths) in the reference period, or are enrolled in a primary health organisation (PHO) during the reference period. The reference period for the FY2022/23 HSU is: 1/7/2022 to 30/6/2023.

Total vaccinations

  Vaccinations last week Cumulative total
First dose 527 4,043,487
Second dose 15 3,986,843
Booster 1 127 2,774,026
Booster 2 734 1,036,127
Booster 3+ 5,133 716,124
Paediatric First Dose 21 272,353
Paediatric Second Dose 4 158,929
Infant First Dose 0 167
Infant Second Dose 0 128
Infant Third Dose 0 84
Total doses 6,561 12,988,268

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Friday 08 March 2024.
  • Vaccinations last week:  Over the 7 days up to and including Friday 08 March 2024.

Booster breakdowns

Booster counts by ethnicity

Ethnicity Booster 1 (16-17) Booster 1 (18+) Booster 2 (50+)
Māori 652 252,520 64,327
Pacific Peoples 437 147,118 28,250
Asian 1,280 440,131 63,764
European/Other 3,999 1,798,294 686,111
Unknown 13 12,221 3,495
Total 6,381 2,650,284 845,947

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
18 to 34 162,359 38,459 23.7%
35 to 49 619,211 121,975 19.7%
50 to 64 721,758 290,034 40.2%
65+ 770,372 555,913 72.2%


This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

*Note, this figure does not include 0-11 year olds

*Note, this figure does not include 0-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings. 

View Medsafe data on COVID-19 vaccine adverse effects following immunisation